SCCS Scientific Advice on the Safety of Triclocarban and Triclosan
The European Commission Scientific Committee on Consumer Safety (SCCS) has published its preliminary version of the scientific advice on the safety of Triclocarban and Triclosan as substances with potential endocrine disrupting properties in cosmetic products. The deadline for comments was set at 27 May 2022.

TRICLOCARBAN AND TRICLOSAN

Triclocarban and Triclosan are ingredients used widely as preservatives in cosmetics and personal care products. They are both included in Annex V (list of preservatives allowed in cosmetic products) of the European Cosmetics Regulation (No. 1223/2009).

Triclocarban (CAS number: 101-20-2) can be used as a preservative up to a concentration of 0.2% in ready for use preparation, subject to purity criteria (Annex V, entry 23). This ingredient is also included in the list of substances which cosmetic products must not contain except subject to the restrictions laid down (Annex III, entry 100). For use other than as a preservative, Triclocarban may be used in rinse-off products up to a maximum concentration of 1.5%, subject to purity criteria.

Triclosan (CAS number: 3380-34-5) can only be used as a preservative in cosmetics. It may be used up to a concentration of 0.2% in mouthwashes and up to 0.3% in other products like toothpastes, hand soaps, body soaps, deodorants (non-spray), face powders, etc. (Annex V, entry 25).

Both Triclosan and Triclocarban have been assessed several times by the European Commission’s Scientific Committee on Consumer Safety (SCCS) and previous committees. These SCCS opinions resulted in the existing regulatory measures that allow different concentration of these ingredients based on the type of product and function.

In early 2019, a priority list of 28 potential endocrine disruptors (not already covered by the bans of cosmetic regulation) was established by the Commission. From these 28 substances, 14 were considered as higher priority (Group A) and the other 14 were included in the low priority group (Group B). The public call for data for the considered higher priority substances was carried out in 2019. Triclocarban and Triclosan were included in the mentioned group for which the call of data took place. (see previous post)

During the call for data, stakeholders submitted scientific evidence to demonstrate the safety of Triclocarban and Triclosan in cosmetic products. The European Commission asked the SCCS to carry out a safety assessment on these two substances considering the information provided.

SCCS SCIENTIFIC ADVICE ON THE SAFETY OF TRICLOCARBAN AND TRICLOSAN

At its plenary meeting on 15-16 March, the SCCS adopted the preliminary version of the scientific advice on the safety of Triclocarban and Triclosan as substances with potential endocrine disrupting properties in cosmetic products.

Based on the available information, including the potential endocrine effects of these ingredients, the SCCS stated that the use of Triclocarban as a preservative in cosmetic products is safe up to a maximum concentration of 0.2% and that this ingredient is also safe up to a maximum concentration of 1.5% in rinse-off products when used individually or in combination, when used with a function other than preservative.

Regarding the use of Triclosan, the SCCS considers that it is safe as a preservative when used individually or in combination up to a maximum concentration of 0.03% in shower gel and hand soap, 0.2% in mouthwash and 0.3% in toothpaste, deodorant stick, face powder and blemish concealer. The SCCS concluded that Triclosan up to a concentration of 0.3% is not safe as preservative in body lotion, but it is safe if its concentration does not exceed 0.03% in this type of cosmetic products.

The SCCS preliminary opinion is open for comments until 27 May 2022.

If you wish to get more information on the safety of cosmetic ingredients, feel free to contact us at info@criticalcatalyst.com.

References:

  1. Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products.
  2. Scientific Committee on Consumer Safety (SCCS). Scientific Advice on the safety of Triclocarban and Triclosan as substances with potential endocrine disrupting properties in cosmetic products. SCCS/1643/22. 2022.

further
reading

cosmetic products

Citral under review: SCCS Preliminary Opinion

The SCCS was tasked by the European Commission to evaluate if the safety levels for Citral, determined through QRA2 based on skin sensitization induction, are sufficient to safeguard consumers. A preliminary opinion was released.

Read More »
cosmetic products

Are sunscreens with Benzophenone-4 safe?

Benzophenone-4 is commonly known as a UV-filter in cosmetic products. Learn what the final opinion of SCCS states about Benzophenone’s safety profile as a UV-filter in cosmetic products.

Read More »
cosmetic products

Is Aluminium in cosmetics safe for human health?

The Scientific Committee on Consumer Safety (SCCS) published its Final Opinion on the safety of Aluminium in cosmetic products. This follows a lengthy review process that began in 2013 when the SCCS was first mandated to evaluate the potential health risks of Aluminium (Al) and its compounds in cosmetics.

Read More »
cosmetic products

Silver in Cosmetics: SCCS preliminary opinion.

Ingredients: SILVER

The recent preliminary opinion from the Scientific Committee on Consumer Safety (SCCS) regarding silver in cosmetics is crucial for consumers and manufacturers. This article breaks down the key points, making it easier to understand the implications and stay informed.

Read More »
news & updates

EU Ecolabel adoption and recognition are on the rise

The Ecolabel certification is a comprehensive program focused on fostering sustainable practices. It evaluates products based on life cycle assessments, where every phase of said life cycle must abide by strict standards to attain the Ecolabel certification. The overarching objective of this certification is minimizing environmental harm from production or consumption activities.

Read More »
cosmetic products

UK proposes ban of wet wipes containing plastic 

The UK has proposed, on April 24, 2024, a regulation titled The Environmental Protection (Wet Wipes Containing Plastic) (England) Regulations 2024, to the World Trade Organization (WTO). The regulation aims to eliminate the supply and sale of plastic-containing wet wipes, including cosmetic ones. The public can offer comments on the draft until June 23, 2024, with adoption expected in September of the same year.

Read More »
news & updates

SCCS preliminary opinion on Citral sensitization endpoint

Ingredients: CITRAL

Date of publication: 27/03/2024

On March 27 2024, the Scientific Committee on Consumer Safety (SCCS) published the Preliminary Opinion on the safety of Citral in cosmetic products. The deadline for comments is set to June 2, 2024.

Read More »
medical devices

Safety Reporting in Clinical Investigations: a Gap Analysis of Guidance Documents 

Safety reporting in clinical investigations of medical devices shall be performed in line with Article 80(2) of the EU MDR. On May 2020, it was published the MDCG 2020-10/1, outlining the procedures for safety reporting in clinical investigations of medical devices under the EU MDR. However, on October 2022 the Medical Device Coordination Group (MDCG) published an updated version of the MDCG 2020-10/1, the MDCG 2020-10/1 Rev 1. This article highlights the updates included in the new revision, analysing the gaps between both documents.

Read More »
medical devices

Roles and Responsibilities of an Authorised Representative under EU MDR and IVDR 

If a medical device manufacturer is not established in a Member State, the devices can only be placed on the Union market if the manufacturer designates an authorised representative. The authorised representative plays a pivotal role in ensuring the compliance of the devices with EU regulation, serving as point of contact. The obligations and responsibilities of authorised representative are outlined on Article 11 of both MDR and IVDR, but clarification of relevant requirements is described in MDCG 2022-16 of October 2022.

Read More »
medical devices

Understanding the ISO Standards Lifecycle

ISO Standards cover a huge range of activities, representing the distilled wisdom of people with expertise in their subject matter and providing the regulators with a sound basis to develop better legislation. ISO Standards are diverse, addressing from the shoe size we wear to the quality of air we breathe. The medical device sector is no exception. ISO has many International Standards and guidance documents aimed at helping the sector ensure safe and effective medical devices while meeting the multitude of national, regional and international regulatory requirements. But how exactly is a Standard developed, reviewed and withdraw?

Read More »